According to FutureWise analysis the market for drug of abuse testing in 2023 was US$ 10.12 billion, and is expected to reach US$ 19.3 billion by 2031 at a CAGR of 8.40%.
Drug abuse refers to the excessive, maladaptive, or addictive consumption of substances for nonmedical purposes, disregarding the potential social, physical, and psychological consequences of such usage. This harmful behaviour involves a range of substances, including anabolic steroids, utilized by certain athletes to expedite muscle growth and enhance strength; however, these steroids can lead to conditions such as heart disease and liver damage. Additionally, psychotropic agents are substances affecting the user's mental state and are employed to induce alterations in mood, perception, and emotions. The group encompasses opium and its derivatives like heroin, hallucinogens, barbiturates, cocaine, amphetamines, tranquilizers, various forms of cannabis, and alcohol. A drug test examines a sample of urine, blood, saliva, hair, or sweat to detect signs of illegal or prescription drug use or misuse, which includes using illicit substances or misusing prescription medications. Drug tests can identify individual drugs or groups of drugs, such as alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, marijuana (THC), opioids, phencyclidine (PCP), and steroids. Usually, urine samples are used, allowing detection within hours to several days before the test, depending on factors like drug type, usage amount, duration, and individual response. Drug testing serves various purposes, including pre-employment screening, on-the-job testing, sports doping checks, monitoring drug treatment, legal investigations, and verifying the proper use of prescription medications. Tests can be scheduled or conducted randomly. It's important to note that while drug testing can indicate drug use or misuse, it cannot diagnose a drug use disorder.
FutureWise Market Research has published a report that provides an insightful analysis of Drug of Abuse Testing Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Drug-of-Abuse/12
Drug of Abuse Testing Market Segmentation:
By Drug Type
- Alcohol
- Cocaine
- Marijuana/Cannabis
- LSD
- Opioids
- Others
By Product
- Analyzers
- Immunoassay Analyzers
- Chromatographic Devices
- Breath Analyzers
- Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
- Consumables
By Sample Type
- Saliva
- Urine
- Blood
- Other Sample Types
By End-User
- Hospitals
- Rehabilitation Centers
- Federal Agencies
- Forensic Laboratories
- Clinics
- Hospitals
- Others
By Application
- Pain Management Testing
- Criminal Justice Testing
- Workplace Screening
By Region
- Europe
- North America
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Drug of Abuse Testing Market:
- Thermo Fisher Scientific
- SYNLAB
- Siemens Healthcare Private Limited
- Roche Diagnostics
- Dragerwerk AGCo KGaA
- Beckman Coulter Inc
- Abbott Laboratories
- Express Diagnostics International Inc
- Shimadzu Corporation
- Laboratory Corporation of America
- Clinical Reference Laboratory (CRL),Inc
- Cordant Health Solutions
- Legacy Medical Services
- Millennium Health
- American Substance Abuse professional (ASAP), Inc
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=12%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Drug of Abuse Testing Market By Drug Type, By Product, By Sample Type, By End-User, By Application and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
